← SynDRA
INDOTECAN
SynDRA canonical compound SYN0006374 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | CHEK1 | PDLIM7 | TOP1 |
|---|
| Mechanism of action | topoisomerase inhibitor |
|---|
| Indication | soft tissue sarcoma (sts) |
|---|
| Disease area | oncology |
|---|
All known targets
Mechanisms of action (all sources)
- topoisomerase inhibitor
- TOP1 INHIBITOR
Cross-references
Synonyms
- LMP400
- UNII-BTA69L5M8D
- NSC-724998
- BTA69L5M8D
- 2,3-dimethoxy-6-(3-morpholinopropyl)-5H-[1,3]dioxolo[4',5':5,6]indeno[1,2-c]isoquinoline-5,12(6H)-dione
- LMP 400
- NSC724998
- Indotecan(LMP400)
- Indotecan (LMP400)
- CHEMBL216462
- SCHEMBL7712572
- DTXSID90238613
- BCP34018
- EX-A3020
- Indotecan hydrochloride (LMP-400)
- ZB1545
- SB16793
- HY-18351
- CS-0007476
- Q27274872
- 3-[(Morpholine)-1-propyl]-5,3-dimethoxy-8,9-meth ylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline
- RefChem:791000
- DTXCID40161104
- LMP-400
- MFCD25977124
- Indotecan(LMP400)?
- orb1308194
- SCHEMBL29409466
- BDBM694222
- AKOS040741879
- AC-35734
- DA-74484
- MS-28890
- US20240287089, Compound LMP400
- G14278
- T15578
- F979283
Look up INDOTECAN in the interactive SynDRA portal →